Birchview Capital as of Dec. 31, 2016
Portfolio Holdings for Birchview Capital
Birchview Capital holds 41 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 55.4 | $90M | 777k | 115.75 | |
| Accelr8 Technology | 27.8 | $45M | 2.2M | 20.75 | |
| EQT Corporation (EQT) | 1.7 | $2.8M | 42k | 65.41 | |
| Vermillion | 1.6 | $2.6M | 2.7M | 0.95 | |
| Masimo Corporation (MASI) | 1.5 | $2.5M | 37k | 67.40 | |
| Biolase Technology | 1.1 | $1.8M | 1.3M | 1.40 | |
| Encana Corp | 1.0 | $1.6M | 132k | 11.74 | |
| Tesaro | 0.8 | $1.3M | 10k | 134.47 | |
| Contrafect | 0.8 | $1.3M | 725k | 1.75 | |
| Oxford Immunotec Global | 0.6 | $1.0M | 67k | 14.95 | |
| Neurocrine Biosciences (NBIX) | 0.6 | $975k | 25k | 38.69 | |
| Merck & Co (MRK) | 0.5 | $883k | 15k | 58.87 | |
| Quidel Corporation | 0.5 | $835k | 39k | 21.42 | |
| NxStage Medical | 0.5 | $739k | 28k | 26.21 | |
| Wright Medical | 0.4 | $689k | 30k | 22.97 | |
| Veracyte (VCYT) | 0.4 | $617k | 80k | 7.74 | |
| Corcept Therapeutics Incorporated (CORT) | 0.4 | $581k | 80k | 7.26 | |
| Oncomed Pharmaceuticals | 0.3 | $545k | 71k | 7.71 | |
| Pioneer Natural Resources | 0.3 | $541k | 3.0k | 180.33 | |
| Sientra | 0.3 | $539k | 63k | 8.52 | |
| Sito Mobile (STTO) | 0.3 | $517k | 140k | 3.69 | |
| Cabot Oil & Gas Corporation (CTRA) | 0.3 | $491k | 21k | 23.38 | |
| Accuray Incorporated (ARAY) | 0.3 | $438k | 95k | 4.60 | |
| Vanda Pharmaceuticals (VNDA) | 0.2 | $351k | 22k | 15.95 | |
| Xencor (XNCR) | 0.2 | $324k | 12k | 26.34 | |
| Celgene Corp right 12/31/2011 | 0.2 | $301k | 292k | 1.03 | |
| Alder Biopharmaceuticals | 0.2 | $315k | 15k | 20.79 | |
| Metabolix | 0.2 | $294k | 2.3M | 0.13 | |
| Biogen Idec (BIIB) | 0.2 | $284k | 1.0k | 284.00 | |
| Quotient | 0.2 | $282k | 58k | 4.85 | |
| Advaxis | 0.2 | $255k | 36k | 7.16 | |
| Aevi Genomic | 0.1 | $249k | 48k | 5.19 | |
| Opko Health (OPK) | 0.1 | $225k | 24k | 9.31 | |
| Coherus Biosciences (CHRS) | 0.1 | $211k | 7.5k | 28.13 | |
| Workhorse Group Inc ordinary shares | 0.1 | $212k | 30k | 7.07 | |
| Roka Bioscience | 0.1 | $198k | 47k | 4.24 | |
| Merrimack Pharmaceuticals In | 0.1 | $180k | 44k | 4.09 | |
| Paratek Pharmaceuticals | 0.1 | $172k | 11k | 15.43 | |
| Genocea Biosciences | 0.1 | $161k | 39k | 4.13 | |
| Cerus Corporation (CERS) | 0.1 | $115k | 27k | 4.34 | |
| Pacific Biosciences of California (PACB) | 0.1 | $103k | 27k | 3.81 |
